Menu Close

Specific multinutrient combination benefits patients with early stage Alzheimer’s disease

A new longitudinal study has shown that a nutritional drink designated a ‘food for special medical purposes’ containing the multinutrient combination Fortasyn Connect® can benefit patients with the earliest stages of Alzheimer’s disease (AD), mild cognitive impairment, who are at risk of progressing to the dementia stage of AD.

Leave a comment

Please log in before commenting